• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000 - 2015年挪威诺尔兰郡肌萎缩侧索硬化症:患病率、发病率及临床特征

Amyotrophic lateral sclerosis in Nordland county, Norway, 2000-2015: prevalence, incidence, and clinical features.

作者信息

Benjaminsen Espen, Alstadhaug Karl B, Gulsvik Marie, Baloch Farid K, Odeh Francis

机构信息

a Department of Neurology , Nordland Hospital , Bodø , Norway.

b Institute of Clinical Medicine, The Arctic University of Tromsø , Tromsø , Norway.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):522-527. doi: 10.1080/21678421.2018.1513534. Epub 2018 Sep 28.

DOI:10.1080/21678421.2018.1513534
PMID:30265157
Abstract

OBJECTIVE

There are some indications of increasing incidence of amyotrophic lateral sclerosis (ALS). Awareness of cognitive impairment in ALS has increased in recent years. We describe the epidemiology and clinical features of ALS in a county in northern Norway over a period of 15 years.

METHODS

All patients with motor neuron disease (MND) living in Nordland County in the period 2000-2015 were identified and the medical records were scrutinized. The average annual incidence was calculated for the whole period and for five-year periods. Prevalence point was 1 January 2015.

RESULTS

We identified 74 cases with MND. The crude point prevalence was 4.1 per 100,000. The average annual incidence was 2.1 per 100,000 for the whole period, 2.0 in the period 2000-2004, 2.3 in 2005-2009, and 2.0 in 2010-2014. All except one of the 22 patients with other forms of MND developed ALS during the course of the disease. The mean survival time was 38 months, patients with bulbar symptoms at diagnosis had a mean survival time of 29 months and those with solely spinal symptoms had a mean survival time of 50 months. Seven patients were diagnosed with frontotemporal dementia (FTD).

CONCLUSION

The incidence was stable during the study period. Other forms of MND converts to clinical ALS given time. Survival time is almost two years shorter in patients with bulbar symptoms at the first examination, compared to those with solely symptoms from spinal muscles. FTD was found in 9% of the patients.

摘要

目的

有迹象表明肌萎缩侧索硬化症(ALS)的发病率在上升。近年来,人们对ALS患者认知障碍的认识有所提高。我们描述了挪威北部一个县15年间ALS的流行病学和临床特征。

方法

确定了2000年至2015年期间居住在诺尔兰郡的所有运动神经元病(MND)患者,并仔细审查了他们的病历。计算了整个时期以及每五年的平均年发病率。患病率计算时间点为2015年1月1日。

结果

我们确定了74例MND患者。粗患病率为每10万人中4.1例。整个时期的平均年发病率为每10万人中2.1例,2000 - 2004年为2.0例,2005 - 2009年为2.3例,2010 - 2014年为2.0例。22例患有其他形式MND的患者中,除1例之外,其余患者在病程中均发展为ALS。平均生存时间为38个月,诊断时出现延髓症状的患者平均生存时间为29个月,仅出现脊髓症状的患者平均生存时间为50个月。7例患者被诊断为额颞叶痴呆(FTD)。

结论

在研究期间发病率稳定。随着时间推移,其他形式的MND会转变为临床ALS。初次检查时出现延髓症状的患者,其生存时间比仅出现脊髓肌肉症状的患者短近两年。9%的患者被发现患有FTD。

相似文献

1
Amyotrophic lateral sclerosis in Nordland county, Norway, 2000-2015: prevalence, incidence, and clinical features.2000 - 2015年挪威诺尔兰郡肌萎缩侧索硬化症:患病率、发病率及临床特征
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):522-527. doi: 10.1080/21678421.2018.1513534. Epub 2018 Sep 28.
2
Incidence and clinical features of amyotrophic lateral sclerosis in Møre and Romsdal County, Norway.挪威摩尔达伦郡肌萎缩侧索硬化症的发病率和临床特征。
Neuroepidemiology. 2011;37(1):58-63. doi: 10.1159/000329523. Epub 2011 Aug 22.
3
Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway.
Acta Neurol Scand. 1991 May;83(5):280-5. doi: 10.1111/j.1600-0404.1991.tb04701.x.
4
[Amyotrophic lateral sclerosis. Occurrence and prognosis].[肌萎缩侧索硬化症。发病率与预后]
Tidsskr Nor Laegeforen. 1991 Sep 10;111(21):2634-6.
5
Epidemiology of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的流行病学
Adv Neurol. 1982;36:281-302.
6
Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.肌萎缩侧索硬化症认知和行为障碍的筛查:异常频率及对生存的影响。
J Neurol Sci. 2017 May 15;376:16-23. doi: 10.1016/j.jns.2017.02.061. Epub 2017 Feb 27.
7
Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.使用药物流行病学方法和贝叶斯多参数证据综合模型估计葡萄牙的肌萎缩侧索硬化症和运动神经元病患病率。
Neuroepidemiology. 2019;53(1-2):73-83. doi: 10.1159/000499485. Epub 2019 May 22.
8
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register.意大利利古里亚地区肌萎缩侧索硬化症的临床流行病学:LIGALS登记册的更新
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct-Nov;17(7-8):535-542. doi: 10.1080/21678421.2016.1197942. Epub 2016 Jul 11.
9
Epidemiology and diagnostic process of amyotrophic lateral sclerosis as distinct from myelopathy: 5-year cohort study of whole-population in South Korea.肌萎缩侧索硬化症与脊髓病不同的流行病学及诊断过程:韩国全人群5年队列研究
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):547-554. doi: 10.1080/21678421.2018.1491600. Epub 2018 Nov 13.
10
Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study.1951 - 2014年挪威肌萎缩侧索硬化症的死亡率趋势:一项年龄 - 时期 - 队列研究
J Neurol. 2016 Dec;263(12):2378-2385. doi: 10.1007/s00415-016-8273-2. Epub 2016 Sep 1.

引用本文的文献

1
Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population-Based Cohort Study.他汀类药物的使用与肌萎缩侧索硬化症的生存率:一项基于人群的队列研究。
Eur J Neurol. 2025 Mar;32(3):e70095. doi: 10.1111/ene.70095.
2
Incidence and mortality of ALS: a 42-year population-based nationwide study.肌萎缩侧索硬化症的发病率和死亡率:一项基于全国人口的42年研究。
J Neurol. 2024 Dec 12;272(1):44. doi: 10.1007/s00415-024-12743-0.
3
Phrenic Nerve Sonography Alterations in Patients with ALS: Insight with Clinical and Neurophysiological Findings.肌萎缩侧索硬化症患者膈神经超声检查的改变:结合临床和神经生理学发现的见解
J Clin Med. 2024 Oct 22;13(21):6302. doi: 10.3390/jcm13216302.
4
Clinical and epidemiological characteristics of amyotrophic lateral sclerosis in an Egyptian cohort.埃及队列中肌萎缩侧索硬化症的临床和流行病学特征
Neurol Sci. 2025 Mar;46(3):1225-1236. doi: 10.1007/s10072-024-07760-w. Epub 2024 Sep 30.
5
Racial Disparities in the Diagnosis and Prognosis of ALS Patients in the United States.美国肌萎缩侧索硬化症患者诊断与预后的种族差异
J Racial Ethn Health Disparities. 2024 Jul 25. doi: 10.1007/s40615-024-02099-6.
6
Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients.导致希腊患者散发性肌萎缩侧索硬化的新型致病性变异。
Genes (Basel). 2024 Feb 28;15(3):309. doi: 10.3390/genes15030309.
7
Increased incidence of motor neuron disease in Sweden: a population-based study during 2002-2021.瑞典运动神经元病发病率上升:一项基于2002年至2021年人口的研究。
J Neurol. 2024 May;271(5):2730-2735. doi: 10.1007/s00415-024-12219-1. Epub 2024 Feb 22.
8
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.对RAS-ALS研究数据的深入分析揭示了雷沙吉兰治疗肌萎缩侧索硬化症的新见解。
Eur J Neurol. 2024 Apr;31(4):e16204. doi: 10.1111/ene.16204. Epub 2024 Jan 19.
9
Sonographic Phrenic Nerve Changes in Amyotrophic Lateral Sclerosis.超声膈神经变化在肌萎缩侧索硬化症中的表现。
Medicina (Kaunas). 2023 Sep 29;59(10):1745. doi: 10.3390/medicina59101745.
10
Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms.调控肌萎缩侧索硬化症皮质兴奋性过高:聚焦于神经胶质机制。
Mol Neurodegener. 2023 Oct 19;18(1):75. doi: 10.1186/s13024-023-00665-w.